IPRATECH

Active

Public limited companyfounded 2007active for 18 yearsAvenue Jean Mermoz 32, 6041 Charleroi, BelgiumKBO/BCE: BE 0893.778.586

Summary

IPRATECH has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.6m and a net result of €98,194. Equity has been growing by about 7.7% per year since 2018. Its solvency ranks better than 38% of 239 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Risk analysisFollow Report Compare

IPRATECHActiveChecked score 68/100

Risk analysis Report Compare

Overview

Official details

Source: KBO

Status: Active since 28-11-2007 Normal situation
Activity: Research and development on biotechnology NACE 72101
Joint committee: 200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2022
Establishment unit: 2.166.840.141 7000 Mons, since 26-11-2007
Financial year end: 31 December
Peppol: Reachable since 12-05-2025

Company details

Board and ownership

Board

David SERGEANTManaging director
CUBETA JérémieDirector · since 30-03-2025
ESTEBAN GeoffreyDirector · since 30-03-2025

and 1 other

Auditor: PRAGMA AUDIT

Shareholders

IMBC SPINNOVA14.92%30-06-2025 annual accounts of IMBC SPINNOVA
VEOSIS5%· score 8430-06-2025 annual accounts of VEOSIS

Holdings: Shares in 3 companies including APICELLS INC and EMMA

Board & ownership

Financial position

68 Healthy Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.8%

Annual accounts 2025

Gross margin: €1.5m; ▲ 57.6%
Turnover: ≈ €2.7m; estimated
Profit: €98,194; ▼ 24.8%
Equity: €1.6m; ▲ 7.4%
Total assets: €4.3m; ▲ 65.0%
Employees on 31-12-2025: 15; ▼ 11.8%

2025 accounts filed 77 days after the deadline

Financials

Score breakdownraises riskLiquidity: current ratio 1.01, cash €45,690Last filed accounts filed 77 days late; 2 of the last 3 accounts latelowers riskFounded in 2007Figures for financial year 2025 (filed on 16-10-2026)Show the evidence

Checked score

Score 2025

68 / 100

Healthy

Probability in this band: 0.55% to 1.5%

Financially stronger than 40% of small companies in research and development (NACE 72)

Every signal that counts is listed under Signals.

Financial strength · tick: 2024

Average

Solvency 61-20

equity 36.5% of total assets

Liquidity 35+2

short-term debt 36.3% · cash 1.1%

Profitability 64-11

return on assets 2.3%

Bankruptcy probability within 12 months

0.8% Low

0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (164 companies, NACE 72, small)

Last 24 months 12-2024: 0.5% 01-2025: 0.5%● unchanged vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025 03-2025: 0.5%● unchanged vs 02-2025 04-2025: 0.3%▼ -0.2 percentage points vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025lowest value 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025 08-2025: 0.7%▲ +0.3 percentage points vs 07-2025 09-2025: 0.9%▲ +0.2 percentage points vs 08-2025 10-2025: 0.3%▼ -0.6 percentage points vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.4%▲ +0.1 percentage points vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.5%▲ +0.1 percentage points vs 06-2026 08-2026: 0.9%▲ +0.4 percentage points vs 07-2026 09-2026: 1.0%▲ +0.1 percentage points vs 08-2026highest value 10-2026: 0.8%▼ -0.2 percentage points vs 09-2026 11-2026: 0.8%● unchanged vs 10-2026

Credit of up to €100,000 on 30-day terms is acceptable

Liquidity is tight, with a current ratio of 1.01 (1.27 in 2024), below the usual 1.5. Short-term debt is 36.3% and cash 1.1% of total assets. 63.5% of the assets are financed with debt and provisions.

Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, small). It does better than 39% of them on solvency, 19% on liquidity, 52% on profitability and 51% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.

lowers riskraises risk

Liquidity: current ratio 1.01, cash €45,690

NBB · annual accounts

Last filed accounts filed 77 days late; 2 of the last 3 accounts late

NBB · filings

Founded in 2007

Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.

KBO

Figures for financial year 2025 (filed on 16-10-2026)

NBB · annual accounts

2025 accounts filed 77 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-10-2026, 77 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

77 days late

2024

60 days late

2023

23 days early

2022

24 days early

2021

27 days early

2020

5 days late

2019

20 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 13 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 July (4 of the last 5 accounts filed within 82 days either side of that date).

Companies Code · seven months

Where today falls in the filing period

05-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Financials

Financials · financial year 2025, full format

2025 annual accounts filed 77 days after the deadline Filed on 16 October 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00560652.

Annual accounts 2025 filed on 16-10-2026 at the NBB all 18 filings

Turnover

≈ €2.7m

Estimated: probably between €1.8m and €4.4m

EBIT margin

Not included in this filing

Net result

€98,194▼ 24.8%

2024 · €130,608

Working capital

€8,509▼ 96.9%

2024 · €272,262

Multi-year overview

2018 to 2025, 8 financial years

Operating result

-€2,313

▲ 82.0% 2025

20182025

Net result

€98,194

▼ 24.8% 2025

middle half of the sector

20182025

Equity

€1.6m

▲ 7.4% 2025

middle half of the sector

20182025

Total assets

€4.3m

▲ 65.0% 2025

middle half of the sector

20182025

Debt

€2.7m

▲ 138% 2025

20182025

Working capital

€8,509

▼ 96.9% 2025

lowest quarter of the sector

20182025

Solvency

36.5%

▼ 19.5pp 2025

middle half of the sector

20182025

Current ratio

1.01

▼ 0.26 2025

lowest quarter of the sector

20182025

Return on assets (ROA)

2.3%

▼ 2.7pp 2025

middle half of the sector

20182025

Staff (FTE)

15.6

▲ 41.8% 2025

middle half of the sector

20182025

Every figure per financial year

Every figure with its change against the financial year before

favourable unfavourable

Line20182019202020212022202320242025

Operating result-€0.06m--€0.01m▲ 79.3%€0.02m€0.05m▲ 147%€0.1m▲ 118%€0.03m▼ 71.6%-€0.01m-€0.002m▲ 82.0%

Net result€0.01m-€0.006m▼ 57.6%€0.01m▲ 124%€0.05m▲ 311%€0.1m▲ 112%€0.1m▲ 5.2%€0.1m▲ 10.9%€0.1m▼ 24.8%

Equity€0.9m-€1.0m▲ 10.1%€1.0m▲ 0.7%€1.1m▲ 9.4%€1.3m▲ 10.6%€1.3m▲ 7.1%€1.5m▲ 8.7%€1.6m▲ 7.4%

Total assets€1.5m-€1.6m▲ 6.1%€1.3m▼ 16.0%€1.6m▲ 18.1%€2.1m▲ 32.5%€2.3m▲ 12.3%€2.6m▲ 11.3%€4.3m▲ 65.0%

Debt€0.6m-€0.6m▼ 0.6%€0.3m▼ 46.9%€0.4m▲ 48.7%€0.8m▲ 88.9%€1.0m▲ 20.1%€1.1m▲ 14.8%€2.7m▲ 138%

Working capital-€0.07m-€0.001m€0.02m▲ 42×€0.1m▲ 455%€0.1m▲ 23.1%€0.2m▲ 63.6%€0.3m▲ 11.5%€0.009m▼ 96.9%

Solvency62.5%-64.9%▲ 2.4pp77.8%▲ 12.9pp72.0%▼ 5.7pp60.1%▼ 11.9pp57.3%▼ 2.8pp56.0%▼ 1.3pp36.5%▼ 19.5pp

Current ratio0.85-1.00▲ 0.151.09▲ 0.091.33▲ 0.241.19▼ 0.141.25▲ 0.061.27▲ 0.021.01▼ 0.26

Return on assets (ROA)0.9%-0.4%▼ 0.5pp1.0%▲ 0.6pp3.4%▲ 2.4pp5.4%▲ 2.0pp5.0%▼ 0.3pp5.0%=2.3%▼ 2.7pp

Staff (FTE)3.7-2.6▼ 29.7%2.8▲ 7.7%4.5▲ 60.7%6▲ 33.3%8.5▲ 41.7%11▲ 29.4%15.6▲ 41.8%

above within below The sector band is the middle half of the companies in Scientific research and development (NACE 72). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.

The operating result for 2025 is a loss of €2,313, smaller than the loss of €12,858 in 2024.

The turnover shown is an estimate from the gross margin.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €4.3m

63.5%

36.5%

Fixed assets €2.7m ▲ 109%

Current assets €1.6m ▲ 20.8%

Equity and liabilities €4.3m

36.5%

63.5%

Equity €1.6m ▲ 7.4%

Debt €2.7m ▲ 138%

Debt's share of the balance-sheet total rises from 44.0% to 63.5%. Equity and debt are higher.

Key figures and ratios

2025 value · change against 2024

EBITDA

€492,971▲

2024 · €276,921

Cash flow

€593,478▲

2024 · €420,388

Quick ratio

0.61▼

2024 · 0.77

Debt to equity

1.74▲

2024 · 0.79

ROE

6.3%▼

2024 · 9.0%

Interest coverage

5.06▼

2024 · 7.75

Debt ≤ 1 year

€1.6m▲

2024 · €1.0m

Debt > 1 year

€1.2m▲

2024 · €115,920

Income taxes

€6,378▲

2024 · -€2,233

Staff costs

€1.0m▲

2024 · €701,525

Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.

Staff

social balance sheet

Item	31-12-2021	31-12-2022	31-12-2023	31-12-2024	31-12-2025
Employees at the balance-sheet date	6	9	11	17	15
full-time	3	7	8	15	14
part-time	3	2	3	2	1
in full-time equivalents	5.5	8.6	9.6	16.4	14.6
Average over the year, in full-time equivalents	4.5	6	8.5	11	15.6
On a permanent contract	4	5	9	17	15
Joined	4	6	10	11	3
Left	1	3	8	5	5
Training hours	213	403	410	248	23

Source: social balance sheet in the 2021 to 2025 annual accounts

Securities and guarantees

on own assets and for others

Item	2021	2022	2023	2024	2025
Debts secured on the company's own assets	€50,000	€190,000	€175,768	€202,618	€1.4m
Debts guaranteed by Belgian public bodies	-	-	-	€97,500	-
Mortgages, amount registered	-	-	-	-	€50,000
Mortgage mandates	-	-	-	-	€950,000
Carrying value of the mortgaged assets	-	-	-	-	€901,506
Pledge on the business	-	€120,000	€120,000	€230,000	€230,000
Carrying value of the other pledged assets	€120,000	-	-	-	-

Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired

Item	2021	2022	2023	2024	2025
Tangible fixed assets	€15,291	€6,535	€121,963	€349,902	€1.8m
Intangible fixed assets	€60,496	€45,046	-	€134,900	€200,000
Financial fixed assets	€998	€62,250	€797	-	€96
Depreciation and write-downs of the year	€58,689	€53,217	€151,093	€289,779	€495,284

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Subsidies and aid

European research

1 project · €150,000 EU contribution

Programmes

Horizon 2020

1 entry · €150,000

Projects

Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production

Horizon 2020 · participant · 01-05-2018 to 31-10-2022 · €150,000 · iConsensus

Public contracts

2 awards · 2024

Fourniture, installation et mise en service de plusieurs plateformes analytiques et technologique dans le cadre du portefeuille PHENIX (Plateformes tecHnologiquEs et aNalytIques d’eXcellence wallonne en agroalimentaire) - Arrêt-relance des lots 2, 3, 4, 5, 6, 11, 12: Lot 5 : Fermenteurs - Petits bioréacteurs indépendants et autoclavables (1L)

buyer: Université de LiègeMachinery for mining and constructionawarded 15-07-2024€115,1573 tendersTED 642199-2024

buyer: Université de LiègeMachinery for mining and constructionawarded 15-07-2024€115,1573 tendersTED 97696-2025

Source: TED (Tenders Electronic Daily), Publications Office of the European Union. The values are as the buyer published them. For a framework agreement, the value is a ceiling.

Annual accounts

OverviewIncome statement Balance sheet Cash flow

Last 5 years All years

Filed annual accounts As filed with the NBB · 2025 against 2024 · 66 lines

Balance sheet Code20242025

Assets

Total assets20/58€2.6m€4.3m▲

Fixed assets21/28€1.3m€2.7m▲

Intangible fixed assets21€0.1m€0.2m▲

Tangible fixed assets22/27€0.2m€1.6m▲

Land and buildings22-€0.9m

Plant, machinery and equipment23€0.07m€0.1m▲

Furniture and vehicles24€0.005m€0.002m▼

Other tangible fixed assets26€0.03m€0.02m▼

Assets under construction and advance payments27€0.1m€0.5m▲

Financial fixed assets28€0.9m€0.9m▼

Current assets29/58€1.3m€1.6m▲

Stocks and contracts in progress3€0.5m€0.6m▲

Stocks30/36€0.5m€0.6m▲

Amounts receivable within one year40/41€0.7m€0.8m▲

Trade receivables40€0.4m€0.2m▼

Other amounts receivable41€0.3m€0.6m▲

Current investments50/53€0.06m€0.06m=

Cash at bank and in hand54/58€0.02m€0.05m▲

Deferred charges and accrued income490/1-€0.004m

Equity and liabilities

Total equity and liabilities10/49€2.6m€4.3m▲

Equity10/15€1.5m€1.6m▲

Contributions10/11€0.9m€0.9m=

Capital10€0.9m€0.9m=

Issued capital100€0.9m€0.9m=

Reserves13€0.5m€0.6m▲

Non-distributable reserves130/1€0.09m€0.1m▲

Legal reserve130€0.03m€0.04m▲

Own shares acquired1312€0.06m€0.06m=

Distributable reserves133€0.4m€0.5m▲

Investment grants15€0.1m€0.1m▲

Amounts payable17/49€1.1m€2.7m▲

Amounts payable after more than one year17€0.1m€1.2m▲

Financial debts170/4€0.1m€1.2m▲

Amounts payable within one year42/48€1.0m€1.6m▲

Current portion of amounts payable after more than one year42€0.09m€0.2m▲

Financial debts43€0.4m€0.4m▼

Credit institutions430/8€0.3m€0.2m▼

Other loans439€0.05m€0.1m▲

Trade debts44€0.1m€0.4m▲

Suppliers440/4€0.1m€0.4m▲

Taxes, remuneration and social security45€0.3m€0.3m▲

Taxes450/3€0.06m€0.04m▼

Remuneration and social security454/9€0.2m€0.2m▲

Other amounts payable47/48€0.1m€0.4m▲

Accrued charges and deferred income492/3€0.005m€0.003m▼

Income statement Code20242025

Remuneration, social security and pensions62€0.7m€1.0m▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.3m€0.5m▲

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€0.004m

Other operating charges640/8€0.002m€0.02m▲

Non-recurring operating charges66A-€340

Gross operating margin9900€1.0m€1.5m▲

Operating profit (loss)9901-€0.01m-€0.002m▲

Financial income75/76B€0.2m€0.3m▲

Recurring financial income75€0.2m€0.3m▲

Financial charges65/66B€0.04m€0.2m▲

Recurring financial charges65€0.04m€0.1m▲

Non-recurring financial charges66B-€0.05m

Profit (loss) for the period before taxes9903€0.1m€0.1m▼

Income taxes67/77-€0.002m€0.006m▲

Profit (loss) for the period9904€0.1m€0.1m▼

Profit (loss) for the period to be appropriated9905€0.1m€0.1m▼

Appropriation of the result

Profit (loss) to be appropriated9906€0.1m€0.1m▼

Transfer to equity691/2€0.1m€0.1m▼

To the legal reserve6920€0.007m€0.005m▼

To other reserves6921€0.1m€0.09m▼

Social balance sheet

Average headcount (FTE)908711.015.6▲

The notes to these accounts have 29 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 16-10-2026.

Line	2018	2019	2020	2021	2022	2023	2024	2025	Change
Non-recurring operating income76A	-	-	-	€0.001m	-	-	-	-	-
Remuneration, social security and pensions62	-	-	-	€0.3m	€0.3m	€0.5m	€0.7m	€1.0m	▲ 46.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€0.2m	€0.07m	€0.05m	€0.06m	€0.05m	€0.2m	€0.3m	€0.5m	▲ 70.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4	-	-	-	-€0.001m	-	-€0.002m	-	€0.004m	-
Other operating charges640/8	-	-	-	€0.003m	€0.007m	€0.003m	€0.002m	€0.02m	▲ 12×
Non-recurring operating charges66A	-	-	-	€0.001m	-	€0.003m	-	€340	-
Gross operating margin9900	€0.3m	€0.2m	€0.2m	€0.4m	€0.5m	€0.7m	€1.0m	€1.5m	▲ 57.6%
Operating profit (loss)9901	-€0.06m	-€0.01m	€0.02m	€0.05m	€0.1m	€0.03m	-€0.01m	-€0.002m	▲ 82.0%
Financial income75/76B	-	-	-	€0.02m	€0.02m	€0.1m	€0.2m	€0.3m	▲ 45.4%
Recurring financial income75	€0.1m	€0.03m	€0.02m	€0.02m	€0.02m	€0.1m	€0.2m	€0.3m	▲ 45.4%
Non-recurring financial income76B	-	-	-	-	-	€0.002m	-	-	-
Financial charges65/66B	-	-	-	€0.01m	€0.02m	€0.03m	€0.04m	€0.2m	▲ 321%
Recurring financial charges65	€0.01m	€0.009m	€0.008m	€0.007m	€0.02m	€0.03m	€0.04m	€0.1m	▲ 172%
Non-recurring financial charges66B	-	-	-	€0.006m	-	-	-	€0.05m	-
Profit (loss) for the period before taxes9903	€0.01m	€0.006m	€0.01m	€0.05m	€0.1m	€0.1m	€0.1m	€0.1m	▼ 18.5%
Income taxes67/77	-€18	-€53	-	-	-€0.006m	-€0.01m	-€0.002m	€0.006m	-
Profit (loss) for the period9904	€0.01m	€0.006m	€0.01m	€0.05m	€0.1m	€0.1m	€0.1m	€0.1m	▼ 24.8%
Profit (loss) for the period to be appropriated9905	€0.01m	€0.006m	€0.01m	€0.05m	€0.1m	€0.1m	€0.1m	€0.1m	▼ 24.8%

Line	2018	2019	2020	2021	2022	2023	2024	2025	Change
Assets
Total assets20/58	€1.5m	€1.6m	€1.3m	€1.6m	€2.1m	€2.3m	€2.6m	€4.3m	▲ 65.0%
Formation expenses20	€0.002m	€0.002m	€0.002m	-	-	-	-	-	-
Fixed assets21/28	€1.1m	€1.1m	€1.1m	€1.1m	€1.1m	€1.1m	€1.3m	€2.7m	▲ 109%
Intangible fixed assets21	€0.1m	€0.2m	€0.2m	€0.2m	€0.2m	€0.1m	€0.1m	€0.2m	▲ 67.8%
Tangible fixed assets22/27	€0.03m	€0.007m	€0.005m	€0.02m	€0.01m	€0.06m	€0.2m	€1.6m	▲ 663%
Land and buildings22	-	-	-	-	-	-	-	€0.9m	-
Plant, machinery and equipment23	-	-	-	€0.009m	€0.008m	€0.005m	€0.07m	€0.1m	▲ 63.8%
Furniture and vehicles24	-	-	-	€0.006m	€0.006m	€0.01m	€0.005m	€0.002m	▼ 49.4%
Other tangible fixed assets26	-	-	-	-	-	-	€0.03m	€0.02m	▼ 22.4%
Assets under construction and advance payments27	-	-	-	-	-	€0.04m	€0.1m	€0.5m	▲ 428%
Financial fixed assets28	€1.0m	€1.0m	€0.9m	€0.9m	€0.9m	€0.9m	€0.9m	€0.9m	▼ 5.6%
Current assets29/58	€0.4m	€0.5m	€0.3m	€0.5m	€0.9m	€1.2m	€1.3m	€1.6m	▲ 20.8%
Stocks and contracts in progress3	€0.1m	€0.1m	€0.1m	€0.2m	€0.3m	€0.4m	€0.5m	€0.6m	▲ 21.3%
Stocks30/36	-	-	-	€0.2m	€0.3m	€0.4m	€0.5m	€0.6m	▲ 21.3%
Amounts receivable within one year40/41	€0.2m	€0.3m	€0.1m	€0.2m	€0.5m	€0.8m	€0.7m	€0.8m	▲ 18.7%
Trade receivables40	-	-	-	€0.2m	€0.3m	€0.3m	€0.4m	€0.2m	▼ 42.9%
Other amounts receivable41	-	-	-	€0.01m	€0.1m	€0.5m	€0.3m	€0.6m	▲ 82.4%
Current investments50/53	-	-	-	-	€0.06m	€0.06m	€0.06m	€0.06m	=
Cash at bank and in hand54/58	-	€0.01m	€0.02m	€0.04m	€0.09m	€0.006m	€0.02m	€0.05m	▲ 133%
Deferred charges and accrued income490/1	-	-	-	€0.005m	€0.005m	€0.002m	-	€0.004m	-
Equity and liabilities
Total equity and liabilities10/49	€1.5m	€1.6m	€1.3m	€1.6m	€2.1m	€2.3m	€2.6m	€4.3m	▲ 65.0%
Equity10/15	€0.9m	€1.0m	€1.0m	€1.1m	€1.3m	€1.3m	€1.5m	€1.6m	▲ 7.4%
Contributions10/11	€0.8m	€0.9m	€0.9m	€0.9m	€0.9m	€0.9m	€0.9m	€0.9m	=
Capital10	-	-	-	€0.9m	€0.9m	€0.9m	€0.9m	€0.9m	=
Issued capital100	-	-	-	€0.9m	€0.9m	€0.9m	€0.9m	€0.9m	=
Reserves13	€0.06m	€0.07m	€0.08m	€0.1m	€0.2m	€0.4m	€0.5m	€0.6m	▲ 20.0%
Non-distributable reserves130/1	-	-	-	€0.01m	€0.08m	€0.09m	€0.09m	€0.1m	▲ 5.2%
Legal reserve130	-	-	-	€0.01m	€0.02m	€0.02m	€0.03m	€0.04m	▲ 16.2%
Own shares acquired1312	-	-	-	-	€0.06m	€0.06m	€0.06m	€0.06m	=
Distributable reserves133	-	-	-	€0.1m	€0.2m	€0.3m	€0.4m	€0.5m	▲ 23.5%
Investment grants15	-	-	-	€0.1m	€0.1m	€0.1m	€0.1m	€0.1m	▲ 10.1%
Amounts payable17/49	€0.6m	€0.6m	€0.3m	€0.4m	€0.8m	€1.0m	€1.1m	€2.7m	▲ 138%
Amounts payable after more than one year17	€0.1m	€0.1m	€0.05m	€0.03m	€0.03m	€0.01m	€0.1m	€1.2m	▲ 905%
Financial debts170/4	-	-	-	€0.03m	€0.03m	€0.01m	€0.1m	€1.2m	▲ 905%
Amounts payable within one year42/48	€0.4m	€0.5m	€0.2m	€0.4m	€0.8m	€1.0m	€1.0m	€1.6m	▲ 52.1%
Current portion of amounts payable after more than one year42	-	-	-	€0.02m	€0.02m	€0.02m	€0.09m	€0.2m	▲ 122%
Financial debts43	-	-	-	€0.05m	€0.2m	€0.2m	€0.4m	€0.4m	▼ 11.9%
Credit institutions430/8	-	-	-	€0.05m	-	-	€0.3m	€0.2m	▼ 39.4%
Other loans439	-	-	-	-	€0.2m	€0.2m	€0.05m	€0.1m	▲ 180%
Trade debts44	€0.08m	€0.2m	€0.06m	€0.2m	€0.3m	€0.3m	€0.1m	€0.4m	▲ 174%
Suppliers440/4	-	-	-	€0.2m	€0.3m	€0.3m	€0.1m	€0.4m	▲ 174%
Advances received on contracts in progress46	-	-	-	-	€0.003m	-	-	-	-
Taxes, remuneration and social security45	-	-	-	€0.09m	€0.1m	€0.2m	€0.3m	€0.3m	▲ 0.5%
Taxes450/3	-	-	-	€0.004m	€0.01m	€0.01m	€0.06m	€0.04m	▼ 43.0%
Remuneration and social security454/9	-	-	-	€0.09m	€0.1m	€0.2m	€0.2m	€0.2m	▲ 13.5%
Other amounts payable47/48	-	-	-	€0.01m	€0.1m	€0.2m	€0.1m	€0.4m	▲ 175%
Accrued charges and deferred income492/3	-	-	-	€0.03m	€0.002m	€0.003m	€0.005m	€0.003m	▼ 45.3%

Line	2018	2019	2020	2021	2022	2023	2024	2025	Change
Profit (loss) for the period9904	€0.01m	€0.006m	€0.01m	€0.05m	€0.1m	€0.1m	€0.1m	€0.1m	▼ 24.8%
+ Depreciation and write-downs630	€0.2m	€0.07m	€0.05m	€0.06m	€0.05m	€0.2m	€0.3m	€0.5m	▲ 70.9%
Operating cash flow (approximation)	€0.2m	€0.08m	€0.06m	€0.1m	€0.2m	€0.3m	€0.4m	€0.6m	▲ 41.2%
Investment in fixed assets (approximation)	-	-€0.07m	€0.008m	-€0.07m	-€0.1m	-€0.1m	-€0.5m	-€1.9m	▼ 295%
Change in cash	-	-	€0.006m	€0.03m	€0.04m	-€0.08m	€0.01m	€0.03m	▲ 89.1%

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 6,049 companies had the same profile as IPRATECH has now. Two years later, 95.9% were still going and 0.4% had gone bankrupt.

Small
10 to 20 years old
solvency 30% or more
a profit under 5% of the balance sheet

95.9% was still going

3.6% stopped otherwise

0.4% went bankrupt

The bankruptcy probability of IPRATECH itself is higher: 0.8% within 12 months. It rests on far more data about IPRATECH than the profile alone.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.5%
3	0.5%	0.6%
4	0.7%	0.8%
5	0.9%	0.9%
6	1.3%	1.5%
7	1.6%	1.8%
8	1.8%	1.8%
9	3.0%	3.1%
10	5.6%	6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,049 companies, not a prediction for IPRATECH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Latest 10 of 18 filings with the National Bank

Financial year	Type	Filed	Reference	Document
31-12-2025	full format	16-10-2026	2026-00560652	PDF
31-12-2024	full format	29-09-2025	2025-00508679	PDF
31-12-2023	full format	08-07-2024	2024-00219213	PDF
31-12-2022	full format	07-07-2023	2023-00219368	PDF
31-12-2021	full format	04-07-2022	2022-20152092	PDF
31-12-2020	full format	05-08-2021	2021-46500147	PDF
31-12-2019	full format	20-08-2020	2020-43000172	PDF
31-12-2018	full format	24-07-2019	2019-37500596	PDF
31-12-2017	full format	30-07-2018	2018-41500418	PDF
31-12-2016	micro format	31-08-2017	2017-60000384	PDF

Show all 18 filings

Board & ownership

Directors

3 directors, 1 in day-to-day management, last change in 2025

Board 3

CUBETA Jérémie

Director · since 30-03-2025 · 3-year term from 2025 · listed in the 2025 annual accounts, filed on 16-10-2026

Current

ESTEBAN Geoffrey

Director · since 30-03-2025 · 3-year term from 2025 · listed in the 2025 annual accounts, filed on 16-10-2026

Current

POSKIN Thierry

Director · since 30-03-2025 · 3-year term from 2025 · also on the board of 2 other companies · listed in the 2025 annual accounts, filed on 16-10-2026

Current

Day-to-day management 1

David SERGEANT

Managing director · in office according to the act of 23-01-2026 · 3-year term from 2025 · also on the board of 1 other company

Current

Statutory auditor 1

PRAGMA AUDIT

Commissaire aux comptes · current term since 16-09-2025 · 3-year term from 2026 · permanent representative: Steve Balcaen · listed in the 2025 annual accounts, filed on 16-10-2026

Current

Office holders in the KBO →

Owners and capital

Shareholders

2 owners

IMBC SPINNOVA
Sourceaccounts IMBC SPINNOVA 30-06-2025
Equity €2.0m Loss of €155,931 in 2025 (profit of €27,638 in 2024)

14.92%
VEOSIS
Sourceaccounts VEOSIS 30-06-2025
Equity €69,417 Profit of €55 in 2025 (profit of €16,091 in 2024) Checked score 84

5%

Owners through the years 2008 to 2025

Owners through the years
Name	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
IMBC SPINNOVA 2008 to 2012: 46.15% 2013 to 2014: 30% 2015 to 2018: 37.64% 2019 to 2022: 29.84% 2023 to 2025: 14.92%	46.15%					30%		37.64%				29.84%				14.92%
VEOSIS 2015 to 2025: 5%								5%

Source: lists of holdings in the owners' accounts

Capital transactions

Capital over time

08-12-2025 Capital stated in the deed · €865,000
27-12-2021 Capital stated in the deed · €865,000 · 4,290 shares

Mandate history

5 people, 5 in office

All 5 In office 5

Board
Day-to-day management
Statutory auditor
mandate already running before its first mention

Mandates per person, with start and end dates
Name	Functions and periods
CUBETA Jérémie	Director, from 30-03-2025 to date
ESTEBAN Geoffrey	Director, since before 30-03-2025
POSKIN Thierry	Director, since before 30-03-2025
David SERGEANT	Managing director, since before 30-03-2025
PRAGMA AUDIT	Commissaire aux comptes, appointed in the act of 03-11-2022, still in office

See the board, name and registered office on a given date →

Articles of association

Board rule: Term of at most 6 years
“Présidence, conseil peut élire président parmi membres”

Articles of association, deed of 27-12-2021 (in French)

Network & group

Holdings and subsidiaries

3 holdings

Source for every holding own accounts 2025

APICELLS INCUSsubsidiary
Equity USD 56,852Result USD 6,030

100%
EMMAsubsidiary
Alsoact 05-05-2026act 08-12-2025act 08-12-2025
Equity €8,381 Loss of €22,678 in 2025 (profit of €10,547 in 2024)

100%
IPRASENSE SASFRsubsidiary
Equity €925,328Result -€9,157

81%

Holdings through the years 2013 to 2025

Holdings through the years
Name	2013	2016	2018	2019	2022	2025
APICELLS INCUS 2013 to 2024: 80% 2025: 100%	80%					100%
EMMA 2022 to 2025: 100%					100%
IPRASENSE SASFR 2016 to 2017: 100% 2018: 84% 2019 to 2025: 81%		100%	84%	81%

Source: list of holdings in its own accounts

Acquisitions and mergers

1 transaction

Took over:EMMA

BE 0783.297.071merger by absorption · Gazette deed of 05-05-2026 (4 acts)

Companies at the same address

3 other companies

Connections & network

2 connected companies

Depth

The connected companies are in the list below.

This company Company Director Shareholding +N: links not shown yet

Linked via shared directors

ACAPELA GROUP BABEL Technologies

via POSKIN Thierry · Director

Founded in 1997 · 29 FTE (2025)

→

MARSTRAND

via POSKIN Thierry · Permanent representative

No longer active · total assets €744,230 (2024)

→

Timeline

Acts, filings and financial milestones

All 20Financial 3Gazette 7Filings 10 of 18

Deadline for the 2026 accounts: 31-07-2027

2026

16-10

NBB filing Annual accounts 2025 filedNBB

full format · 77 days late

05-05

Gazette deed Merger: IPRATECH takes over EMMA

“toutes activités se rapportant à: - L'exercice d'activité de recherche et de développement de procédés…” (deed in French) · The company holds all the shares of EMMA4 points ▸

General meeting, 10-03-2026
The company holds all the shares of EMMA
Purpose change, “toutes activités se rapportant à: - L'exercice d'activité de recherche et de développement de procédés industriels (biotechnologie, gestion de parcs d'automates…” (deed in French)
Registered-office move, Gosselies, rue Clément Ader
The act holds 5 more points.

Open the act in the Belgian Official Gazette

23-01

Gazette deed 1 director appointed, 3 directors reappointed

Reappointments: David SERGEANT, POSKIN Thierry and 2 others · Appointment: CUBETA Jérémie (director)6 points ▸

General meeting, 16-09-2025
Director reappointment, David SERGEANT (managing director)
Director reappointment, POSKIN Thierry
Director reappointment, ESTEBAN Geoffrey
Director appointment, CUBETA Jérémie
Auditor reappointment, PRAGMA AUDIT (commissaire aux comptes)

Open the act in the Belgian Official Gazette

2025

08-12

Gazette deed Merger proposal: IPRATECH takes over EMMA

The company holds all the shares of EMMA6 points ▸

Capital, €865,000
Capital, €61,500
Director in office, David Sergeant, mentioned 2 times in the deed
Director in office, Thierry POSKIN, mentioned 2 times in the deed
The company holds all the shares of EMMA
Accounting effect, 01-01-2026
The act holds 4 more points.

Open the act in the Belgian Official Gazette

29-09

NBB filing Annual accounts 2024 filedPDF

full format · 60 days late

2024

31-12

Financial Highest result from 2018 to 2025net €130,608 ▲10.9%

The net result of €130,608 is the highest of those years.

08-07

NBB filing Annual accounts 2023 filedPDF

full format · 23 days before the deadline

2023

07-07

NBB filing Annual accounts 2022 filedPDF

full format · 24 days before the deadline

31-03

Gazette deed Registered office moved within Gosselies

New seat: Avenue Jean Mermoz, 32 B 6041 Gosselies · Previous seat: Avenue Jean Mermoz 30 à 6041 Gosselies2 points ▸

Board meeting, 16-12-2022
Registered-office move, Avenue Jean Mermoz, 32 B 6041 Gosselies

Open the act in the Belgian Official Gazette

2022

03-11

Gazette deed Reappointment: PRAGMA AUDIT (statutory auditor)

Director discharge: PRAGMA AUDIT (commissaire réviseur)2 points ▸

Director discharge, PRAGMA AUDIT (commissaire réviseur)
Auditor reappointment, PRAGMA AUDIT (statutory auditor)

Open the act in the Belgian Official Gazette

04-07

NBB filing Annual accounts 2021 filedPDF

full format · 27 days before the deadline

2021

27-12

Gazette deed Registered office moved from Mons to Gosselies

New seat: avenue Jean Mermoz 30, 6041 Gosselies · Previous seat: rue de l'Epargne 56, 7000 Mons · Registered office clause: avenue Jean Mermoz 30, 6041 Gosselies4 points ▸

General meeting, 23-12-2021
Registered-office move, avenue Jean Mermoz 30, 6041 Gosselies
Capital, €865,000, 4,290 shares
Registered office clause, avenue Jean Mermoz 30, 6041 Gosselies
The act holds 4 more points.

Open the act in the Belgian Official Gazette

Show earlier events

05-08

NBB filing Annual accounts 2020 filedPDF

full format · 5 days late

2020

20-08

NBB filing Annual accounts 2019 filedPDF

full format · 20 days late

2019

31-12

Financial Weakest financial yearnet €5,736 ▼57.6%

The net result drops to €5,736, the lowest from 2018 to 2025. It recovers the following year.

31-12

Financial Equity above €1mequity €1.0m ▲10.1%

With a profit in every financial year since 2018, equity grows to €1.0m.

24-07

NBB filing Annual accounts 2018 filedPDF

full format · 7 days before the deadline

2018

30-07

NBB filing Annual accounts 2017 filedPDF

full format · 1 day before the deadline

2017

31-08

NBB filing Annual accounts 2016 filedPDF

micro format · 31 days late

2007

07-12

Gazette deed IncorporationPDF

Show all 18 filings

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

Sources:Publications in the Belgian Official Gazette Filings with the National Bank

History

IPRATECH was incorporated on 28 November 2007.¹ The registered office was moved to Gosselies in 2021.² In 2026 the company absorbed EMMA by merger.³

Company details

Register details

Identity

KBO record

Name IPRATECH in French

Enterprise number 0893.778.586

Legal form Public limited company

Status Active, normale toestand

Founded 28-11-2007

Entity type Legal entity

Duration

Unlimited

deed of 27-12-2021 (in French)

Registered office and establishments

Registered office Avenue Jean Mermoz 32, 6041 Charleroi, Belgium

1 former office

7000 Mons until the act of 27-12-2021

Establishment unit Ipratech, Rue de l'Epargne 56, 7000 Mons since 26-11-2007 · unit number 2.166.840.141

Activities

NACEBEL 2025

VAT activities

72101 Research and development on biotechnology main activity

Social security (RSZ) activities

72101 Research and development on biotechnology main activity

Codes under NACEBEL 2008

VAT activities

72110 Scientific research and development main activity

Social security (RSZ) activities

72110 Scientific research and development main activity

Codes under NACEBEL 2003

73100 main activity

Joint committee 200 Aanvullend Paritair Comité voor de bedienden annual accounts 2022

Purpose

“L'exercice d'activité de recherche et de développement de procédés industriels (biotechnologie, gestion de parcs d'automates, ...); Le…”

3 activities

L'exercice d'activité de recherche et de développement de procédés industriels (biotechnologie, gestion de parcs d'automates, ...)
Le développement et commercialisation de produits ou services informatiques et électroniques
La gestion des propriétés industrielles liées aux activités ci-avant décrites

deed of 27-12-2021 (in French)

Invoicing and payment

VAT number BE 0893.778.586

E-invoicing via Peppol

Reachable via Peppol

Peppol ID 0208:0893778586

Other Peppol ID 9925:BE0893778586

Registered 12-05-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Financial year and general meeting

Accounts at the NBB

Financial year end 31-12

Annual meeting

Last Friday of May at 10:00

deed of 27-12-2021 (in French)

Sites & property

Location

registered office establishment approximate The establishment unit on the map

4 companies at this address See who is registered here

Buildings and parcels at the address

Ground area

2,954 m²

Building footprint

671 m²

Building volume

5,032 m³

Cadastral parcel	Region	Area	Buildings	Height / floors
52028B0315/18E000	Wallonia	2,954 m²	1 · 670 m²	10.0 m · 2

Overview

Overview

Official details

Board and ownership

Financial position

Checked score

Signals

Financials

Financials · financial year 2025, full format

Staff

Securities and guarantees

Investments

Subsidies and aid

European research

Public contracts

Historical observation

Board & ownership

Directors

Board 3

Day-to-day management 1

Statutory auditor 1

Owners and capital

Shareholders

Owners 2

Capital transactions

Mandate history

Articles of association

Network & group

Holdings and subsidiaries

Holdings 3

Acquisitions and mergers

Companies at the same address

Connections & network

Timeline

Acts, filings and financial milestones

History

Company details

Register details

Identity

Registered office and establishments

Activities

Invoicing and payment

Financial year and general meeting

Sites & property

Buildings and parcels at the address